B Morein|S Höglund - JoVE Visualize

Showing results (81-90 of 186) with videos related to

Pageof 19

Sort By:

Vaccine|December 31, 1997

Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicityB Rönnberg, M Fekadu, S Behboudi, et al.

Acta Medica Scandinavica|January 1, 1975

Changes in certain iron metabolism variables after a single blood donationG Liedén, S Höglund, L Ehn

Cellular Immunology|September 1, 1990

Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrixC Fossum, M Bergström, K Lövgren, et al.

Medical Microbiology and Immunology|January 1, 1987

Monocyte and iscom enhancement of cell-mediated response to cytomegalovirusB Wahren, S Nordlund, A Akesson, et al.

Acta Medica Scandinavica|January 1, 1975

[Iron supplement to blood donors. II. Effect of continuous iron supply]G Liedén, S Höglund, L Ehn

Medicine and Science in Sports and Exercise|January 1, 1980

Iron status in athletes involved in intense physical activityL Ehn, B Carlmark, S Höglund

FEMS Immunology and Medical Microbiology|September 11, 2001

Different respiratory syncytial virus and Quillaja saponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profilesK F Hu, M Chen, I Abusugra, et al.

Scandinavian Journal of Immunology|October 1, 1992

Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical formsM Bergström-Mollaoglu, K Lövgren, L Akerblom, et al.

European Journal of Immunology|November 1, 1988

In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340D Ulaeto, L Wallace, A Morgan, et al.

AIDS Research and Human Retroviruses|August 1, 1992

Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challengeA Osterhaus, P de Vries, B Morein, et al.

Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:

Pageof 19

Vaccine|December 31, 1997

Effects of carbohydrate modification of Quillaja saponaria Molina QH-B fraction on adjuvant activity, cholesterol-binding capacity and toxicityB Rönnberg, M Fekadu, S Behboudi, et al.

Acta Medica Scandinavica|January 1, 1975

Changes in certain iron metabolism variables after a single blood donationG Liedén, S Höglund, L Ehn

Cellular Immunology|September 1, 1990

Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrixC Fossum, M Bergström, K Lövgren, et al.

Medical Microbiology and Immunology|January 1, 1987

Monocyte and iscom enhancement of cell-mediated response to cytomegalovirusB Wahren, S Nordlund, A Akesson, et al.

Acta Medica Scandinavica|January 1, 1975

[Iron supplement to blood donors. II. Effect of continuous iron supply]G Liedén, S Höglund, L Ehn

Medicine and Science in Sports and Exercise|January 1, 1980

Iron status in athletes involved in intense physical activityL Ehn, B Carlmark, S Höglund

FEMS Immunology and Medical Microbiology|September 11, 2001

Different respiratory syncytial virus and Quillaja saponin formulations induce murine peritoneal cells to express different proinflammatory cytokine profilesK F Hu, M Chen, I Abusugra, et al.

Scandinavian Journal of Immunology|October 1, 1992

Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical formsM Bergström-Mollaoglu, K Lövgren, L Akerblom, et al.

European Journal of Immunology|November 1, 1988

In vitro T cell responses to a candidate Epstein-Barr virus vaccine: human CD4+ T cell clones specific for the major envelope glycoprotein gp340D Ulaeto, L Wallace, A Morgan, et al.

AIDS Research and Human Retroviruses|August 1, 1992

Comparison of protection afforded by whole virus ISCOM versus MDP adjuvanted formalin-inactivated SIV vaccines from IV cell-free or cell-associated homologous challengeA Osterhaus, P de Vries, B Morein, et al.

Pageof 19